Navigation Links
Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Date:10/15/2007

erse reactions are cytopenias, infusion reactions, and immunosuppression/infections.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,500 employees in locations spanning the globe and 2006 revenues of $3.2 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation. In 2006 and 2007, Genzyme was selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Genzyme Hosts Investor Call This Morning

Genzyme will host an investor call with Professor Alastair Compston this morning, Monday, October 15, from 8:30-9:30 a.m. EST. Three-year, top-line data from the Phase 2 study will be presented and there will be opportunity for investors to ask questions of the alemtuzumab investigator.

To participate in the call, please dial 1-888-889-4416 in the U.S. or 1-773-756-0616 outside of the U.S. The participant passcode is "Genzyme."

A replay of this call will be available by dialing 203-369-3276. This call will also be available live on the investor events section of http://www.genzyme.com. Replays
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
4. Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
5. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
6. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
7. Cobalis Expects to Report Phase III Top-Line Results in May
8. XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
9. Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntingtons Disease
10. UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across the ... select Meijer pharmacies in Michigan will ... eligible patients, enabling Meijer pharmacists to administer tests and, in ... by a physician participating in the study. The ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 1 Allen Medical Systems, a Hill-Rom company, (NYSE: ... Spotlight Series showcasing interviews with top orthopaedic surgeons. Carlos ... Institute, is the featured surgeon and is recognized for ... Intraoperative Arm Positioner for elbow fractures, scopes and clavicle ...
... Therapeutics, Inc. (OTC Bulletin Board: ECTE), a ... as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) ... delivery, announced today that Patrick T. Mooney, M.D., Chairman ... Annual JMP Securities Healthcare Conference on Tuesday, October 6, ...
Cached Medicine Technology:Allen Medical Systems Announces Surgeon Spotlight Series Interview 2Allen Medical Systems Announces Surgeon Spotlight Series Interview 3Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference 2
(Date:7/10/2014)... (PRWEB) July 10, 2014 Ivalua, ... latest results of the 4th “Trending in Procurement” ... model. , Every day multinational corporations process ... expense forms etc. To meet this challenge, more ... suites which can be defined as a suite ...
(Date:7/10/2014)... 2014 (HealthDay News) -- Nature, not nurture, may play ... chimpanzees, a new study finds. "As is the ... cognitive [thinking] abilities in chimpanzees," William Hopkins of the ... a news release from the journal Current Biology ... the evolution of intelligence in humans, Hopkins, team said. ...
(Date:7/10/2014)... who are sensitive to light or noise after a ... as anxiety and depression, a new study says. ... teens experience after concussion may help in planning for ... to return to play and what accommodations are needed ... and Dong Han, of the University of Kentucky in ...
(Date:7/10/2014)... Dennis Thompson HealthDay Reporter ... Twitter wars that break out regularly between outspoken celebrities or ... your own relationship, a new study suggests. High amounts ... even if the couple is in a long-term relationship, according ... In turn, that friction can lead to cheating and ...
(Date:7/10/2014)... Emergency Medical Service (EMS) responders felt better prepared to ... tactical training according to a new study in the ... the first study to specifically examine the EMS provider ... a shooter has not yet been neutralized or working ... such as the Columbine High School shooting, the Virginia ...
Breaking Medicine News(10 mins):Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 3Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Active shooter training increases comfort level of emergency responders 2
... ... study finds that generic drugs to be equally as effective as brand name drugs. ... (PRWEB) November 19, 2009 -- ... the fear many people have about generic drugs. A systematic review of 47 studies comparing ...
... ... Month and to promote nutritional education, diet delivery company Bistro MD is holding a ... enter. , ... November 19, 2009 -- In celebration of National Novel Writing Month and to promote ...
... ... allows users to perform feature based reverse engineering functions with new added functionality ... ... 2009 -- Creative Dezign Concepts Inc today announced that DezignWorks, a feature ...
... , BEIJING, Nov. 19 ... ), a leading China-based,medical device company that develops, manufactures and ... the second fiscal quarter ended September 30, 2009 ("2Q FY2009"). ... ("FY2009"). , , 2Q FY2009 Highlights, ...
... 18 The American Association of Homes and Services for ... on ensuring that the Community Living and Supportive Services (CLASS) ... Long-term services and supports are an essential part of health ... of reform. We are also grateful to Sen. Dodd (D-Conn.) ...
... , CHICAGO, Nov. 18 Smoking cigarettes not only contributes ... pain and spine problems, according to recent studies and observations ... encouraging Americans to "kick the habit" during the Nov. 19 ... the American Cancer Society. Throughout this month, Dr. Karahalios will ...
Cached Medicine News:Health News:Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve 2Health News:Diet Delivery Company Bistro MD Is Giving Away $1,500 in First Ever Creative Writing Contest 2Health News:Diet Delivery Company Bistro MD Is Giving Away $1,500 in First Ever Creative Writing Contest 3Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 2Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 3Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 4Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 5Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 2Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 3Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 4Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 5Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 6Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 7Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 8Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 9Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 10Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 11Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 12Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 13Health News:China Medical Technologies Reports Second Fiscal Quarter Financial Results 14Health News:AAHSA Statement on Senate Health Reform Bill 2Health News:Smoking Contributes to Back Pain and Ineffective Surgical Treatments 2Health News:Smoking Contributes to Back Pain and Ineffective Surgical Treatments 3
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
Medicine Products: